Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-19-011709
Filing Date
2019-09-13
Accepted
2019-09-13 17:15:16
Documents
6
Effectiveness Date
2019-09-13

Document Format Files

Seq Description Document Type Size
1 S-8 auph-2019x08x06formsx8.htm S-8 142913
2 EXHIBIT 5.1 exhibit51opinionofbordenla.htm EX-5.1 10088
3 EXHIBIT 23.2 exhibit232consentofpricewa.htm EX-23.2 2594
4 EXHIBIT 99.3 exhibit993optioncommitment.htm EX-99.3 10907
5 auriniaconsentletterforms8se.jpg GRAPHIC 111894
6 aurinialogonovember2018.jpg GRAPHIC 179789
  Complete submission text file 0001628280-19-011709.txt   569100
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233765 | Film No.: 191093219
SIC: 2834 Pharmaceutical Preparations